Skip to content
← Back to this collection

PUBLICATIONS · 12531809

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2003 May 15
First author
Bostrom BC

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Bostrom BC
      type
      Author
    2. name
      Sensel MR
      type
      Author
    3. name
      Sather HN
      type
      Author
    4. name
      Gaynon PS
      type
      Author
    5. name
      La MK
      type
      Author
    6. name
      Johnston K
      type
      Author
    7. name
      Erdmann GR
      type
      Author
    8. name
      Gold S
      type
      Author
    9. name
      Heerema NA
      type
      Author
    10. name
      Hutchinson RJ
      type
      Author
    11. name
      Provisor AJ
      type
      Author
    12. name
      Trigg ME
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Bostrom BC
      type
      Author
    2. name
      Sensel MR
      type
      Author
    3. name
      Sather HN
      type
      Author
    4. name
      Gaynon PS
      type
      Author
    5. name
      La MK
      type
      Author
    6. name
      Johnston K
      type
      Author
    7. name
      Erdmann GR
      type
      Author
    8. name
      Gold S
      type
      Author
    9. name
      Heerema NA
      type
      Author
    10. name
      Hutchinson RJ
      type
      Author
    11. name
      Provisor AJ
      type
      Author
    12. name
      Trigg ME
      type
      Author
    bibliography ids
    1. nci-bib-9811b45cf0cc9feb88d88154
    book metadata
    content sha256
    cfc58f2f0b10a5a668d5223856f891698dd54a9ca323a3d9a628815cc8442142
    document type
    citation
    dois
    1. 10.1182/blood-2002-08-2454
    electronic publication date
    display
    2003 Jan 16
    precision
    day
    year
    2003
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:12531809
    immutable id
    pubmed:12531809@cfc58f2f0b10a5a668d5223856f891698dd54a9ca323a3d9a628815cc8442142
    journal
    abbreviation
    Blood
    issn electronic
    Source null
    issn print
    0006-4971
    issue
    10
    name
    Blood
    nlm unique id
    7603509
    pages
    3809-17
    volume
    101
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      12531809
      provenance
      batch id
      6646708a43dc2007bef0
      provider
      NCBI PubMed ESummary
      record sha256
      c50e979407b44bcdf4dd1e58d664bf394949e14d384d814b244576bf0a9f2f89
      response sha256
      2e7ae6114dac3dd1eb0d8799c51ad362081554b4e07621e9ff80c0fb43c178c7
      retrieved at
      2026-09-09T23:45:48.511831+00:00
      publication date
      display
      2003 May 15
      precision
      day
      year
      2003
      publication types
      1. Clinical Trial
      2. Comparative Study
      3. Journal Article
      4. Multicenter Study
      5. Randomized Controlled Trial
      6. Research Support, U.S. Gov't, P.H.S.
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/12531809/
      title
      Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.

      Preserved source evidence · Not medical advice